Clinical Trial Update: A Registry-based Cluster Randomized Trial to Compare the Effect of Spironolactone vs. Eplerenone on Clinical Outcomes in Patients With Symptomatic Systolic Heart Failure [Phase 4]

View source ↗

Summary

A registry-based cluster randomized trial comparing spironolactone versus eplerenone in symptomatic systolic heart failure (Phase 4), currently enrolling by inv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systolic Heart Failure

Drugs mentioned

• Spironolactone (spironolactone)
• eplerenone (eplerenone)

Snippet

Sponsor: Bispebjerg Hospital | Conditions: Systolic Heart Failure | Phase 4 | Status: ENROLLING_BY_INVITATION